Global Neuromodulation Devices and Implantable Infusion Pumps Competitive Landscape Professional Research Report 2025

Research Summary

Neuromodulation devices and implantable infusion pumps are medical devices used in the field of neurology to treat various neurological conditions. Neuromodulation devices, such as deep brain stimulation (DBS) systems, spinal cord stimulators (SCS), and transcranial magnetic stimulation (TMS) devices, deliver targeted electrical or magnetic stimuli to specific areas of the nervous system to modulate abnormal neural activity and alleviate symptoms. DBS systems involve surgically implanting electrodes in the brain and connecting them to a pulse generator, which delivers electrical impulses to targeted brain regions. SCS devices use electrical stimulation in the spinal cord to manage chronic pain. TMS devices employ magnetic fields to non-invasively stimulate particular brain regions to treat conditions like depression and migraines.

Implantable infusion pumps, on the other hand, are used to deliver medications directly into the body, typically via a catheter or tube connected to the pump. These pumps are implanted surgically under the skin and are programmable to deliver precise doses of medications, such as pain relievers, muscle relaxants, or anti-spasticity drugs, directly to the spinal cord or specific areas of the brain.

Both neuromodulation devices and implantable infusion pumps provide targeted therapy for neurological conditions, offering a more precise and effective approach compared to systemic drug delivery methods. They are utilized in the management of conditions such as chronic pain, movement disorders (like Parkinson’s disease), epilepsy, obsessive-compulsive disorder (OCD), and other neurological disorders. These devices require careful evaluation, patient selection, and ongoing monitoring to ensure safety and optimize therapeutic outcomes.

According to DIResearch's in-depth investigation and research, the global Neuromodulation Devices and Implantable Infusion Pumps market size was valued at XX Million USD in 2024 and is projected to reach XX Million USD by 2032, with a CAGR of XX% (2025-2032). Notably, the China market has changed rapidly in the past few years. By 2024, China's market size is expected to be XX Million USD, representing approximately XX% of the global market share. By 2032, it is anticipated to grow further to XX Million USD, contributing XX% to the worldwide market share.

The major global  manufacturers of Neuromodulation Devices and Implantable Infusion Pumps include Medtronic, Boston Scientific Corporation, Abbott, Synapse Biomedical, Nevro Corporation, Neuropace, Cyberonics, Autonomic Technologies, Avery Biomedical, Greatbatch Medical etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.

This report studies the market size, price trends and future development prospects of Neuromodulation Devices and Implantable Infusion Pumps. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Neuromodulation Devices and Implantable Infusion Pumps market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Neuromodulation Devices and Implantable Infusion Pumps market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Neuromodulation Devices and Implantable Infusion Pumps industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.  

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Neuromodulation Devices and Implantable Infusion Pumps Include:

Medtronic

Boston Scientific Corporation

Abbott

Synapse Biomedical

Nevro Corporation

Neuropace

Cyberonics

Autonomic Technologies

Avery Biomedical

Greatbatch Medical

Neuromodulation Devices and Implantable Infusion Pumps Product Segment Include:

Spinal Cord Stimulation

Deep Brain Stimulation

Sacral Nerve Stimulation

Vagal Nerve Stimulation

Gastric Stimulation

Transcranial magnetic Stimulation

Transcutaneous Electrical Stimulation

Other

Neuromodulation Devices and Implantable Infusion Pumps Product Application Include:

Parkinson＇s disease

Epilepsy

Pain

Other

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global Neuromodulation Devices and Implantable Infusion Pumps Industry PESTEL Analysis

Chapter 3: Global Neuromodulation Devices and Implantable Infusion Pumps Industry Porter’s Five Forces Analysis

Chapter 4: Global Neuromodulation Devices and Implantable Infusion Pumps Major Regional Market Size (Revenue, Sales, Price) and Forecast Analysis

Chapter 5: Global Neuromodulation Devices and Implantable Infusion Pumps Market Size and Forecast by Type and Application Analysis

Chapter 6: North America Neuromodulation Devices and Implantable Infusion Pumps Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe Neuromodulation Devices and Implantable Infusion Pumps Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China Neuromodulation Devices and Implantable Infusion Pumps Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) Neuromodulation Devices and Implantable Infusion Pumps Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America Neuromodulation Devices and Implantable Infusion Pumps Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global Neuromodulation Devices and Implantable Infusion Pumps Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources